Using a new type of array technology, the reverse phase protein array (RPPA), we measure time-course protein expression for a set of selected markers that are known to co-regulate biological functions in a pathway structure. To accommodate the complex dependent nature of the data, including temporal correlation and pathway dependence for the protein markers, we propose a mixed effects model with temporal and proteinspecific components. We develop a sequence of random probability measures (RPM) to account for the dependence in time of the protein expression measurements. Marginally, for each RPM we assume a Dirichlet process (DP) model. The dependence is introduced by defining multivariate beta distributions for the unnormalized weights of the stick breaking representation. We also acknowledge the pathway dependence among proteins via a conditionally autoregressive (CAR) model. Applying our model to the RPPA data, we reveal a pathway-dependent functional profile for the set of proteins as well as marginal expression profiles over time for individual markers.
1. Introduction
Functional Proteomics
Functional proteomics is a systemic biological tool concerned with probing the protein functions and their interaction with therapeutic regimens. Instead of studying individual protein expression, system biologists now try to decode the behavior of an entire protein pathway, including protein-protein interaction. Typically, a form of stimulus (such as a drug and/or small interfering RNAs) is given to the biological system. The system is then observed over time and the expression of all the proteins in disease-related pathways is measured. Such experiments allow biologists and clinicians to directly investigate causal relationships between the stimulus and the protein markers as well as the pathway dependence among the markers.
We analyze data from a functional proteomics profiling experiment using reverse phase protein arrays (RPPA) (Tibes et al., 2006) . RPPA is a high-throughput functional proteomic technology that quantifies the expression for targeted proteins. Researchers can print on each array more than 1,000 individual patient samples containing the whole cellular protein repertoire in batches. On the slides, each sample can be recognized as a square matrix of dots, which represent a dilution series used for quantification of protein expression. Each slide is probed with an antibody that represents one specific protein. Researchers choose specific pathways they want to target, usually containing 50-200 proteins, and produce the same number of arrays, with each array hybridized against one protein. Because of the reversed design (as compared to the microarray), RPPA's allow much larger sample sizes than the traditional microarrays and therefore allow for higher statistical power in detecting protein interactions.
The RPPA data presented here are time-course data for proteins on a signaling pathway over time after an initial intervention. We characterize the effect of the intervention by inference on the changing distribution of protein activation over time. The changing distribution summarizes the treatment effect on the entire pathway. Taking a Bayesian perspective, the desired inference requires a prior probability model for this sequence of random distributions.
Probability models for random distributions are traditionally known as nonparametric Bayes models. See, for example, Hjort et al. (2010) for a recent review. One of the most popular nonparametric Bayesian models is the Dirichlet process (DP) model (Ferguson, 1973) . Extending the DP model we define a non-parametric Bayesian model for a time series of random probability measures. Additional protein-specific random effects account for dependence of proteins on the same pathway.
An RPPA study
We recently performed pathway inhibition experiments to study the therapeutic effects of FDA-approved drugs on ovarian cancer cell lines. Focusing on disease markers in the EGFR/PI3K pathway (Figure 1 ), we aim to investigate how Lapatinib, an EGF (epidermal growth factor) inhibitor, impacts cellular signaling networks. We formalize the research question as inference on the distribution on protein activation over time for the proteins on the EGFR/PI3K pathway. In other words, we are interested in the shift of the distribution over time.
In the experiment, an ovarian cell line was initially treated with Lapatinib, and then stimulated with EGF over time. At D = 8 time points, t d = 0, 5, 15, 30, 60, 90, 120, and 240 minutes, about 30 proteins were probed using RPPA. For each protein, three replicate expression intensities were recorded. We normalized the data such that each protein has a median expression level of 1,000. We then log-transformed the data and computed difference scores as defined for the significance analysis of microarrays method (Tusher et al., 2001) . The difference scores are between post-treatment and pre-treatment intensities for each protein at each time point. This pre-processing of the data is necessary in order to make expressions comparable across proteins. We first undertake a frequentist analysis of the data using the Bioconductor package Linear Models for Microarray Data (LIMMA). Specifically, we propose a linear model with two covariates, protein as a factor with 30 levels (indexed by i), and a partition of the eight times points into four groups (denoted by c d * , d * = 1, 2, 3, 4). In particular, c 1 * = {0}, c 2 * = {5, 15, 30}, c 3 * = {60, 90, 120}, and c 4 * = {240}. We set the base line time point 0 as the first group. Then whenever the time is doubled, we define a new group. Denote y di the difference score of protein i at time d. A negative value of y di implies suppression of protein expression
. . , D} = {0, 1, 1, 1, 2, 2, 2, 3} be the group label under the above partition. For each protein, LIMMA fits a linear model of the form,
We then assess the contrasts that compare the differences between β i,0 (the fitted base-line mean at time 0) versus other β i,C d in which C d = 0. This allows us to see if the protein expression changed over time groups. We apply the empirical Bayes shrinkage estimation to calculate moderated t-statistics (Smyth, 2004) and adjust the p-values based on the false discovery rate (FDR) approach in Benjamini and Hochberg (1995) . These are all standard procedures in the LIMMA package. (Figure 3 ), this protein corresponds to the one with the largest differences in its expression at almost all the time points relative to time point 0. We need a more detailed modeling and decided to pursue a fully model-based Bayesian inference. As Section 5.3 shows, the alternative approach discovers interesting and plausible new findings that echo biological belief.
Random effects model
The Bayesian analysis aims to achieve three objectives, (i) to characterize the time-varying distribution of protein activation over time; (ii) to identify proteins that are suppressed due to deactivation of the pathway by Lapatinib; and (iii) to account for the protein-protein interaction in the pathway. To this end we propose the following random effects model. Let
. . , D denote a time-varying distribution of protein activations. Let u i denote protein-specific random effects. We use u i to account for (known) dependence of proteins in the pathway. Let y di denote the observed difference in expression for protein i at time d. We assume that y di arises from the model
with independent residuals di ∼ N (0, τ d ) and
. . , D} characterize the time-varying activation of the pathway after adjusting for protein-specific effects.
The experiment includes data on some control proteins. These are proteins that are not expected to respond to Lapatinib treatment and are included for verification purposes. Due to the inclusion of these control proteins, we expect multi-modality in the distributions F d . This is confirmed by Figure 2 . Beyond this, it is difficult to predict specific features of the time-varying distributions. These considerations rule out the use of standard parametric models. Instead, we introduce a variation of the nonparametric dependent Dirichlet process model, namely the time-series dependent Dirichlet process (tsDDP), to capture the temporal effects of Lapatinib on the entire protein pathway. For the protein-specific random effects u i we use a conditionally autoregressive (CAR) model to account for the pathway dependence among proteins.
The contents of the rest of the paper is described as follows. In Section 2 we introduce a novel dependent Dirichlet process to model the temporal effects. Pathway dependence is modeled via a conditionally autoregressive model which is described in Section 3. In Section 4 we deal with implementation issues and derive an efficient algorithm for carrying out posterior inference. Results from the analysis of the RPPA data are presented in Section 5 and the paper concludes with some remarks in Section 6.
Time-Varying Protein-Activation

Dependent DP Models
One of the inference goals is modeling of the time-varying distributions, F = {F d , d = 1, . . . , D}, of protein-activation. We introduce a novel model for a time series of random probability measures (RPM's), p(F). In particular, we propose dependent RPMs with Dirichlet process (DP) marginal distributions (Ferguson, 1973) . We define the joint model on the sequence of RPMs F by assuming discrete RPMs with common locations of point masses and varying, but dependent, weights. This construction allows us to specify different strengths of dependence in different parts of the sample space. This feature becomes relevant when, for example, two RPMs are judged to be similar in the center of the distributions, but outliers are likely to be quite different, as is the case for the RPPA data.
The DP prior (Ferguson, 1973) is indexed by two parameters, a total mass parameter c and base measure G. We write F ∼ DP(c, G). The base measure defines the expectation, i.e., E(F ) = G and the total mass parameter can be interpreted as a precision parameter; the larger c, the closer the random F is to G.
MacEachern (1999) introduced a general idea to define dependent DP (DDP) as a way of extending the DP model to multiple random measures F = {F x , x ∈ X}. Since the DP generates almost surely (a.s.) discrete RPM, we can write F x (·) = h w xh δ µ xh (·), where δ m denotes a point mass at m and w xh and µ xh are random quantities. The key idea behind the DDP is to introduce dependence across the measures F x by assuming that the distribution of the point masses µ xh are dependent across different levels of x but still independent across h. Alternatively the dependence across x can be introduced on the weights w xh , keeping the model unchanged marginally, for fixed x. There are several ways to achieve this.
For instance, in the basic version of the DDP the weights are assumed constant across x,
i.e., w xh = w h , and the dependence of µ xh 's across x could be obtained by using a Gaussian process (MacEachern, 1999) . Alternatively, DeIorio et al. (2004) indexed F x with categorical factors x to define an analysis of variance type dependence of the µ xh across x. Moreover, Gelfand et al. (2005) worked with spatial data and defined dependence through a spatial Gaussian process. In a time series setting, taking x to be time, Caron et al. (2007) and Rodriguez and Ter Horst (2008) considered dynamic DP models by introducing first order dependence in the µ xh via a generalized Polya urns scheme and a dynamic linear model respectively. Recently, Barrientos et al. (2011) have shown that, however the dependence is introduced in the model, weights and/or locations, the DDP has full weak support.
Our proposed model is a special case of the general DDP model introduced in MacEachern (1999). Most definitions of DDP models, including all examples above except for Griffin and Steel (2006) , introduce the desired dependence on the locations µ xh . In contrast, we proceed by introducing the dependence through the weights. We believe dependence on the weights and common locations to be more natural for time series analysis than common weights and dependent locations. From a data analysis point of view, the former corresponds to discretizing the sample space, with a common discretization over the sequence of random measures. The latter can be interpreted as a discretization on the probability scale.
In two other independent works, Taddy (2010) and Griffin and Steel (2011) proposed stick breaking autoregressive models, which include the DP as special case. In particular, Griffin and Steel (2011) 
Time-Series DDP
We define a probability model for a sequence of dependent measures
Sethuraman's (1994) stick breaking representation for an RPM
The random cumulative distribution function has steps of size w dh at
We introduce dependence between (F d , F d+1 ) by the following construction. We assume common locations µ dh = µ h for all d = 1, . . . , D, and introduce the desired dependence through the weights. We introduce latent binomial random variables (r.v.) that link v dh and v d+1,h , and thus (w dh , w d+1,h ).
Specifically, the joint distribution p(F 1 , . . . , F D ) is defined by considering the stick breaking representation (2) for each
together with a joint distribution for (v 1h , . . . , v Dh ) assumed to be a Markov process similar to the one considered by Nieto-Barajas and Walker (2002) . It is defined conditional on latent variables z dh :
We refer to the joint model for (F 1 , . . . , Equations (3) define a joint distribution for v dh and z dh . The role of the latent variable z dh is to introduce dependence between the pair (v dh , v d+1,h ). The strength of the dependence is specified by m dh . A larger binomial sample size m dh implies higher correlation. In fact,
In the limiting case when m dh → ∞, we get equal weights (i.e., v dh = v d+1,h w.p. 1) and, doing so for all d and h, we obtain identical random One way of assessing the dependence structure induced by our model is by considering the correlation between the probability masses of distributions F d and F d+1 . This correlation is shown in the following Proposition.
where for i = 1, 2, . . . , and d = 1 . . . , D − 1,
and
See (4) below for a highly simplified expression in an important special case.
The proof is postponed to the Appendix. The correlation between two adjacent RPMs is larger in regions where the prior mean G assigns more probability. That is, the prior model places the strongest dependence in the most probable regions according to G. The expression greatly simplifies when m dh = m d for all h. It can be shown that the correlation in this case simplifies to
Recall that a value of m dh = 0 implies independence between (v dh , v d+1,h ). However, formula (4) indicates that even if v dh is independent of v d+1,h ∀h, F d is still correlated with F d+1 due to the common point masses µ dh . In fact, for the same simplified case when
. Note that a moderate to strong dependence in the measures F d and F d+1 does not imply a strong dependence in the observations x di and x d+1,j .
Consider the extreme case when m dh → ∞, i.e.
, implies that Corr(x i , x j ) = 1/(c+1) which can cover the whole range in (0, 1).
Thus, for finite m dh this correlation should be lower, i.e. Corr(x di , x d+1,j ) ≤ 1/(c + 1). For most time-course problems one would assume at least moderate correlations in the measures.
The restriction to ρ ≥ 1/2 is therefore reasonable. In summary we assume
Since the distributions
are dependent, adjacent effects (x di , x d+1,j ) are also (marginally) dependent after integrating with respect to the RPMs F d 's. Equations (1) and (5) can be viewed as a dynamic state space model (Harrison and Stevens, 1976) .
Pathway Dependence
The second important component in model (1) are the protein-specific effects u i 's. A dependent prior on u = (u 1 , . . . , u n ) accounts for dependence of proteins on the common pathway.
We assume known dependence structure, summarized in the consensus pathway shown in Figure 1 . We represent this (known) dependence as a conditional autoregressive (CAR) model, originally studied by Besag (1974) . The general specification of the CAR model for
where I is the identity matrix, B is an n × n matrix such that b ii = 0, D λ = diag(λ i ) and α is such that αω i < 1 for i = 1, . . . , n, with ω i the eigenvalues of B (Wall, 2004) . Different choices of matrices D λ and B produce different CAR models. In particular, Cressie (1973) suggests to use
where W denotes the adjacency matrix of the protein interaction, such that w ii = 0 and w ii = 1 if proteins i and i are neighbors (i ∼ i ). We will use this latter specification of Cressie.
We define the proximity matrix W as follows: Considering the pathway diagram in Figure 1 , we first remove the feedback loop from p70 to EGFR to interpret the graph as a directed acyclic graph (Thulasiraman and Swamy, 1992) . We then marginalize with respect to the proteins that are not recorded in the data and finally use moralization to define a neighborhood structure for u. Any protein that was recorded in the data, but does not feature on the pathway, is simply included without neighbors.
To ensure propriety of model (6), the association parameter needs to satisfy the condition (Cressie, 1973) , α ∈ (γ We will consider a prior distribution for α in its range of values by translating a beta distribution. That is, if we want α ∈ (c 1 , c 2 ) we will take α = c 1 + (c 2 − c 1 )X with X ∼ Be(a, b).
In notation we will say that α ∼ TBe(a, b, c 1 , c 2 ). The model is completed by considering a prior distribution on the precision parameter λ of the form λ ∼ Ga(α λ , β λ ).
Posterior inference
An important feature of the proposed model is the easy implementation of posterior MCMC simulation. The key problem is to sample from the posterior distribution of the random distributions F d . To this end we propose a collapsed Gibbs sampler based on marginalizing with respect to the non-allocated point masses in the stick breaking representation of F d , similar to Papaspiliopoulos and Roberts (2008) .
Recall that our model is defined by equations (1), (5) and (6) together with its hyperprior distributions on prior parameters c, m, λ and α. Additionally, a prior distribution is assumed for the residual precision,
For the following discussion it is convenient to rewrite
We also introduce notation that will be helpful. Let k = {k di , i = 1, . . . , n d , d = 1, . . . , D} denote the set of latent indicators and k * = {k * 1 , . . . , k * s } denote the set of unique values in k. Also, let µ * = {µ h , h ∈ k * } denote the set of point masses that are linked with the latent variables x di 's. We set H = max{k * }, i.e., H is the highest index of a point mass µ h that is sampled as a latent x di . Recall from Proposition 1 that c and m dh control the level of dependence.
We use the data to set values for the remaining parameters c and m by including them in the unknown parameter vector and completing the model with a hyperprior on (c, m). We assume c ∼ Ga(α c , β c ) and m ∼ TPo(ξ, κ) independently a priori, where TPo(ξ, κ) denotes a truncated Poisson distribution with intensity ξ and upper bound κ. Moreover, the centering measure G is considered to be a N(µ 0 , τ 0 ).
For later reference we denote the complete parameter vector as
Here v = (v dh , d = 1, . . . , D, h = 1, . . . , H). We only include the weights for point masses 1 through H and locations for allocated point masses, h ∈ k * . The remaining parameters, including weights beyond H and non-allocated locations µ h , h ∈ k * , are not required in the following posterior simulation. In other words, we can analytically marginalize with respect to these parameters, allowing us to define posterior simulation for p(θ | data). Note that θ includes s ≤ H locations µ * , but exactly H weights v dh (for each d), i.e., locations of allocated point masses only, but weights of all point masses with indices up to H. (Tierney, 1994) . The posterior conditional distributions can be found in the Appendix in the Supplementary Material. Fortran code for implementing this model can be obtained upon request from the first author.
Posterior inference is implemented via Markov chain Monte Carlo (MCMC) simulation
Ishwaran and James (2001) proposed a general algorithm for carrying out posterior inference in stick breaking processes that is similar to ours in the sense that it works with the posterior distribution of the whole process. Their method is called the blocked Gibbs sampler, which is an approximation to the posterior distribution of the process. Our algorithm involves no approximation and is computationally efficient due to the marginalization wherever possible.
Data Analysis
MCMC implementation and hyperparameters
We carry out inference for the time-course RPPA data described in the Introduction by implementing the random effects model (1), (5) CAR models have better performance for values of α close to the upper limit. We will consider noninformative and informative priors for α to compare.
We ran the Gibbs sampler for 300,000 iterations with a burn-in of 50,000. After burn-in we saved the imputed state every 10th iteration. We assessed model fit using the logarithm of the pseudomarginal likelihood (LPML) statistic (Gelfand et al., 1992) , which is a summary of the individual conditional predictive ordinates (CPO). Alternative ways of model comparison rely on the use of Bayes factors. However, according to Basu and Chib (2003) , Bayes factors for Dirichlet processes mixture models are technically difficult to compute and instead they suggest to compute CPOs for model comparison.
We considered models with combinations of Ga(1, 1) or Ga(0.1, 0.1) priors on c, and to the prior choice of α. We find better fit under an informative prior for α, TBe(18, 2, c 1 , c 2 ), versus a flat prior TBe (1, 1, c 1 , c 2 ) . This confirms Carlin and Banerjee (2003) who observed that values of α closer to the upper limit better capture the dependence and result in a better fit.
Alternative models
Before we proceed with data analysis, we compare the proposed model versus other alternatives. The first alternative model (Model M1) assumes a temporal random effect common to all individuals of the form
assumes a common temporal effect for all individuals but with a quadratic shape (suggested by the data) of the form
Since the proposed model assumes a time series of random distributions {F d }, a natural simplification could be to consider a common random distribution for all d's. Thus, the third alternative model, Model M3, uses F d ≡ F with F ∼ DP(c, G). The last two competing models belong to the general class of DDP models (MacEachern, 1999) but in contrast to our proposal, impose the dependence in the locations instead of the weights. Model M4 is a linear DDP, a straightforward extension of DeIorio et al. (2004) , with
M5 simplifies the latter model and borrows strength across time by considering a common intercept and slope in time for each individual, that is, In M2 we fixed φ = 0.1. In M3, M4 and M5 we assumed c ∼ Ga(1, 1) . Again, LPML statistics were computed to assess model fitting. We found LP M L = 34. 98, 38.17, −1.28, 14.80, 39.75 for models M1 through M5, respectively. The the DDP model M5 provides the best fit.
The second best fitting is the parsimonious quadratic model M2. However, cross examining the LPML values obtained by our model and the five competing models, reveals that the proposed new model compares favorably against all alternative models considered.
Results
We now report posterior inference under the proposed model. In the sequel we consider the model with prior specifications: c ∼ Ga(1, 1), m ∼ TPo(1, 5) and α ∼ TBe(18, 2, −0.43, 0.17).
For Recall that m controls the degree of dependence in the unnormalized weights in the stickbreaking representation that defines the tsDDP. The larger m, the stronger the dependence.
To better understand the impact of c and m in the posterior inference, we computed the pairwise correlations between adjacent distributions F d 's, using Proposition 1. Figure 4 shows the evolution of the correlation
whose expression in given in (4). For the distributions separated by 5 minutes, F 1 and F 2 , there is a high correlation of around 0.883, whereas for those distributions with a separation of 120 minutes, F 7 and F 8 , the correlation reduces to 0.681. unaffected. This is represented by the (practically) invariable probability mass around x ≥ 0 (i.e., no difference to baseline t 1 = 0) in panel (b).
For the protein specific random effects, there are two parameters which play an important role in the determination of the CAR model. The parameter λ is the precision of the random effects around a linear combination of the neighbors' random effects (Carlin and Banerjee, 2003) . The posterior mean of λ is 23.71 with a 95% credible interval (10.49, 46.59), which suggests a moderate to large precision. The other parameter is α. This parameter is usually referred to as the spatial association parameter (Carlin and Banerjee, 2003) . Remember that, to ensure the propriety of the prior for u, α is bonded to lie between −0.43 and 0.17, reciprocals of the minimum and maximum eigenvalues of the adjacency matrix. After assigning an informative prior, the posterior estimate of α is 0.114, with P(α > 0 | rest) = 0.99, which confirms the significance of the association parameter α and implies a positive dependence among neighbor proteins in the consensus pathway of Figure 1 .
To assess model fit we present in Table 1 Table   1 , pAKT.S473, Lapatinib shows a short and long term effect, it has a stronger suppressing effect immediately after the drug was administered (i.e., at times t = 0 and t = 5), then it vanishes and the effect comes back in time t = 240. On the other hand, for proteins like pS6, in its two versions, the suppressing effect of Lapatinib is constant, varying smoothly over time.
From the CPO values (Table 1) together with the evolution of the observed difference scores (Figures 2 and 3 ), we deduce that there are some proteins that consistently show a negative difference score across observation times. To identify such proteins we consider the (estimated) individual protein-specific effect u i for each of the proteins, i = 1, . . . , 30. Table 1 (last two columns) lists the posterior means E(u i | data), together with the posterior probability of the random effect being negative P(u i < 0 | data). If we control the Bayesian false discovery rate (FDR) (Newton et al., 2004) to be at most 10%, we detect nine proteins being significantly suppressed by Lapatinib. They have been highlighted in bold face in the last column of Table 1 pathway (Hennessy et al., 2005) . The same authors also show that JNK is regulated by ASK1 which in turn is inhibited by AKT. Proteins p70S6K and s6 were expected to be inhibited when phosphorylated since they are controls. AKT is the second protein downstream of EGFR in the pathway. Therefore, our inference confirms the relationship between EGFR and AKT.
Considering the pathway diagram, it is surprising that EGFR did not show any significant suppression. However, in this ovarian cell line, EGFR is not highly expressed in the first place, and therefore not expected to be significantly suppressed. We see some suppression
in Table 1 but only at low levels, confirming this expectation. For proteins LKB1, PKC and mTOR, which are also part of the pathway, we found out that the reagents for these proteins are of poor quality. Therefore, even though they are downstream of EGFR in the pathway, they are not expected to be suppressed due to technical issues. This is confirmed in Table   1 . There are three proteins GSK3, JNK and cJun that were significantly suppressed but are not part of the pathway. We believe that the suppression of GSK3 and JNK are due to the suppression of AKT. Specifically, Diehl et al. (1998) and Hennessy et al. (2005) respectively showed that AKT inhibits GSK3 and JNK. The suppression of cJun is a surprising result since Lochhead et al. (2001) showed that GSK3 inhibits cJun. Therefore, suppression of the GSK3 should lead to activation of cJun. The fact that cJun is also suppressed implies that there could be other unknown mechanism related to the regulation of cJun.
Discussion
In pursuing an analysis of functional proteomics data, we proposed a random effects model with protein-specific and temporal components. For the protein-specific components we considered a CAR model that accounts for the pathway interaction among proteins. For the temporal effects, we have introduced a new time series DDP model. The main feature of this latter model is a non-exchangeable dependence structure for the random distributions In general, the time series DDP model is suitable whenever a random distribution evolves over time and a flexible nonparametric model is desired. Additionally, it is particularly useful when the interest is the identification of subpopulations that might move differently over time than others, as was the case for the inhibited and non-inhibited proteins in the RPPA dataset. Additionally, the model is capable of dealing with unbalance designs with different time points for different samples.
We focused on the random effects, spatial and temporal, since these are the elements of interest in the motivating application. However, in many other data analysis problems the investigator might be interested in the clustering that is inherent to the DP mixture As an overall conclusion from the data analysis, we note that the epidermal growth factor pathway, presented in Figure 1 , has been confirmed, with exceptions in some proteins like EGFR for the particular case of the ovarian cell line. The most important findings are the new discoveries of proteins that were not previously thought to be part of the pathway. These findings shed some light in the understanding of the ovarian cancer that need immediate attention and further study.
Finally, we did not extensively investigated frequentist operating characteristics for the tsDDP model. We expect them to be comparable to the BAR model of Taddy (2010) since both models allow for dependence of the stick breaking unnormalized weights. 
